208

CHAPTER 1 INTRODUCTION:

1. De-Smet, PGAM. The role of plant derived drugs and herbal medicines in healthcare, Drugs.

1997; 54: 801-840.

2. Winslow L, Kroll DJ. Herbs as Medicines, Archives of Internal Medicine. 1998; 158: 2192 -

2199.

3. Gossell M, Simon OR, West ME. The past and the present use of plants for medicines. West

Indian Medical Journal. 2006; 55: 217.

4. WHO Technical report series. Guidelines for the Assessment of Herbal Medicines. 1996;

863: 178-184.

5. Abhishek K, Ashutosh M and Sinha BN. Herbal drugs- present status and efforts to promote

and regulate cultivation. The Pharma Review. 2006; 6: 73-77.

6. Harish P. Herbal drugs. Current Science. 2001; 81(1): 15.

7. Catherine C, Crone MD, Thomas N and Wise MD. Use of herbal medicines among

consultation-liaison populations. The Academy of Psychosomatic Medicine. 1998; 39(1): 3-

13.

8. Akerele O.Summary of WHO guidelines for the assessment of herbal

medicines,HerbalGram. 1993; 28: 13-19.

9. Benedum J. In Phytopharmaka IV. Rietbrock. 1998; 3.

10. Patwardhan B, Warude D, Pushpangadan P and Bhatt N. Ayurveda and Traditional Chinese

Medicine: A Comparative OverviewEvidence-Based Complem. Altern. Med. 2005; 2: 465.

209

11. Nortier JL, Martinez MCM, Schmeiser HH, Arlt VM and Bieler A et al., Urothelial

carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)Engl. J. Medicine.

2000; 342: 1686.

12. Bent S and Ko R. Standardization of herbal medicines. Am. J. Med.2004; 116: 478.

13. Manoj S et al., Pharmacovigilance of herbal medicines. The Pharma Review. 2006; 12: 119-

124.

14. Routledge P. 150 Years of pharmacovigilance. The Lancet. 1998; 351: 1200-1201.

15. Bigoniya P. Pharmacovigilance of herbal medicines: current status and future strategies. The

Pharma Review. 2009; 5: 77-88.

16. Sukhdev S, Arun N and Kalia AN. Patentability of herbal products: A review. The Pharma

Review. 2008; 4: 118-124.

17. Raskin L et al., Plants and human health in the twenty first century”, Trends in

Biotechnology. 2002; 220(12): 522-531.

18. Sovova M, Sova P (May 2004). Pharmaceutical importance of Allium sativum L. 5.

Hypolipemic effects in vitro and in vivo, Ceska Slov Farm (in Czech) 53 (3): 117–23.

CHAPTERS 2 REVIEW OF LITERATURE:

1. Vinodhini S, Malairajan S and Hazeena B. The Hepatoprotective Effect of Bael Leaves

(Aegle Marmelos) in Alcohol Induced Liver Injury in Albino Rats. International Journal of

Science & Technology. 2007; 2(2): 83-92.

210

2. Rajamanickam V. Detoxifying effect of Nelumbo nucifera and Aegle marmelos on

hematological parameters of Common Carp (Cyprinus carpio L.). Interdiscip. Toxicol. 2010;

3(4): 127–131.

3. Balakumar S, Rajan S , Thirunalasundari T, Jeeva S. Antifungal activity of Aegle marmelos

(L.) Correa (Rutaceae) leaf extract on dermatophytes. Asian Pacific Journal of Tropical

Biomedicine. 2011; 309-312.

4. Pushpendra KP, Jyoti S, Lokesh S, Narendra K, Prajapati, Dubey BK Aegle marmelos:A

Review on its Medicinal Properties. Int.J.Pharm.Phytopharmacol.Res. 2012; 1(5): 332-341.

5. Surat L, Chalita P, Cholpisut T, Somsak T, Suphara T and Wanwasan N. Chemical

Constituents from Aegle marmelos.J. Braz. Chem. Soc., 2011; 22(1): 176-178.

6. Rekha W, Jasmine V and Priyadharshini P. In Vitro Propagation of Aegle Marmelos L.

(Corr.) From Mature Trees through Enhanced Axilliary Brancing. Asian J. Exp. Biol. Sci.

2010; l 1(3): 669-676.

7. Alka C, Meera A, Sonalika K & Anju M. Antifertility studies of Aegle marmelos Corr., an

Indian medicinal plant on male albino rats. Egyptian Journal of Biology. 2008; 10: 28-35.

8. Rohini SK, Neha SV, Sachin MM. International Journal of Applied Biology and

Pharmaceutical Technology. 2011; 2(1): 154 – 161.

9. Prabhjit K, Amandeep W, Subodh K and Satwinderjeet K. Antigenotoxic Activity of

Polyphenolic Rich Extracts from Aegle marmelos (L.) Correa in Human Blood Lymphocytes

and E.coli PQ 37. Rec. Nat. Prod. 2009; 3(1): 68-75.

10. Dinesh KS, Gaurav K, Karthik L and Bhaskara R. A review on pharmacological and

phytochemical properties of Aegle marmelos (L.) Corr. Serr. (Rutaceae). Asian Journal of

Plant Science and Research. 2011; 1(2): 8-17.

211

11. Purnima S and Debjani G. Aegle Marmelos Enhances Gastric Mucosal Protection: Relevance

for NSAIDS-Induced Gastric Mucosal Injury. Al Ame en J Med Sci. 2012 ; 5(3): 243 -255.

12. Sandeep D, Ruhil S, Balhara M, Dhankhar S and Chhillar AK. Aegle marmelos (Linn.)

Correa: A potential source of Phytomedicine. Journal of Medicinal Plants Research. 2011;

5(9): 1497-1507.

13. Arun K, Balasubramanian U. Comparative study on Hepatoprotective activity of Aegle

marmelos and Eclipta alba against alcohol induced in albino rats. International Journal of

Environmental Sciences. 2011; 2(2): 389 – 402.

14. Rajesh K, Ashok K, Chandra SP, Nawal KD and Raju S. Insecticidal Activity Aegle

marmelos (L.) Correa Essential Oil Against Four Stored Grain Insect Pests. Internet Journal

of Food Safety. 2008; 10: 39-49 .

15. Narayan PY, Chanotia CS. Phytochemical and Pharmacological Profile of Leaves of Aegle

Marmelos Linn. The Pharma Review. 2009; 144 – 150.

16. Remya M , Sharma RC, Haidar S, Rakshit JUA and Singh S. In vitro effect of Aegle

marmelos on human sperm Motility. Journal of Medicinal Plants Research. 2009; 3(12):

1137-1139.

17. Sevugan A, Subramanian K, Balamuthu K, Abdul BAA, Mohammed AA, Mandali VR.

Antidiabetic activity of leaf and callus extracts of Aegle marmelos in rabbit. ScienceAsia.

2008; 34: 317-321.

18. Nadeem AS, Mohd M, Abdul KN and Mohd A. Evaluation of antioxidant activity,

quantitative estimation of phenols and flavonoids in different parts of Aegle marmelos.

African Journal of Plant Science. 2010; 4(1): 001-005.

212

19. Balasubramanian P, Jayalakshmi K, Vidhya N, Prasad R, Khaleefathullah S, Kathiravan G,

K. Rajagopal K and Sripathi MS. Antiviral activity of ancient system of ayurvedic medicinal

plant Cissus quadrangularis L. (Vitaceae). Journal of Basic and Clinical Pharmacy. 2010;

1(1): 37 – 40.

20. Bhagath KP, Kumar MRB,Muddanna SR,Gopalan KN, Mallikarjuna RC,Soubhagya

RN,Manjunatha SM. Petroleum Ether Extract Of Cissus Quadrangularis (Linn.) Enhances

Bone Marrow Mesenchymal Stem Cell Proliferation And Facilitates Osteoblastogenesis.

CLINICS. 2009;64(10):993-8.

21. Sarath BK, Jayakumar K, Santhosh JM, Chakravarthy K, Ashok P. Antioxidant activity of

cissus quadrangularis on sodium perchlorate-induced oxidative damage in rats. Int J Med

Health Sci. 2012; 1(1): 13 – 18.

22. Krunal VN, Jignesh K and Sumitra VC. Pharmacognostical And Phytochemical Evaluation

of Stem of Cissus Quadrangularis L. IJPSR. 2011; 2(11): 2856-2862.

23. Bhagath KP, Muddanna SR, Gopalan KN, Mallikarjuna RC, Soubhagya RN, Huban T. Anti-

osteoporotic Activity of the Petroleum Ether Extract of Cissus quadrangularis Linn. in

Ovariectomized Wistar Rats. Chang Gung Med J. 2010; 33(3): 252 – 257.

24. Vijayakumari P, Shanthi K , Bharathi K, Kayalvizhi J, Muruganantham G, Sethuraman M

and V.Thirumurugan. Studies on the Physico-Phytochemical and Anti-diabetic Properties of

Cissus quadrangularis l. and Solanum torvum swartz. Int. J. of Drug Discovery & Herbal

Research. 2012; 2(1): 323-328.

25. Shah U. Pharmacognostical investigation on Cissus quadrangularis linn. International

Journal of Pharma and Bio Sciences. 2010; 1(3): 1 – 5.

213

26. Merinal S and Viji SBG. In-vitroscreening of antimicrobial potentials of Cissus

quadrangularis L. Asian Journal of Plant Science and Research. 2012; 2 (1): 58-62.

27. Deka DK, Lahon LC, Saikia J, Mukit A. The Effect Of Clssus Quadrangular/S In

Accelerating Healing Process of Experimentally Fractured Radius-Ulna Of Dog: A

Preliminary Study. Indian Journal of Pharmacology. 1994; 26: 44 – 45.

28. Ashutosh M, Anuj KA, Amiya RP. Indian Medicinal Plant Cissus quadrangularis Linn. An

Ethnobotanical And Ethnomedicinal Review. Herbal Tech Industry. 2010; 15 – 17.

29. Viswanatha Swamy AHM, Thippeswamy AHM, Manjula DV and Mahendra Kumar CB.

Some Neuropharmacological Effects of the Methanolic Root Extract of Cissus

Quadrangularis in Mice. African Journal of Biomedical Research. 2006; 9: 69 – 75.

30. Ngo Bum E, Ngoupaye GT, Talla E, Dimo T, Nkantchoua GCN, Pelanken MM and Taiwe

GS. Anticonvulsant and sedative properties of stems of Cissus quadrangularis in mice.

African Journal of Pharmacy and Pharmacology. 2008; 2(3): 042-047.

31. Sukij P, Surath S, Chairath S, Charuwan M. Experimental Comparative Study of the Efficacy

and Side Effects of Cissus quadrangularisL. (Vitaceae) to Daflon (Servier) and Placebo in

the Treatment of Acute Hemorrhoids. J Med Assoc Thai. 2010; 93( 12): 1360 – 1367.

32. E.Mohanambal , K.Shobana , M. Sowmya Sree , G.M.Kusuma , K.Satish & B.Vijayakumar

. Isolation of Alcoholic Extract of Cissus Quadrangularis and Evaluation of In- Vitro

Anthelmintic Activity. Internationl journal of novel trends in pharmaceutical scicences. 2011;

1(1): 6-9.

33. Achal Thakur, Vandana Jain, L Hingorani, KS LaddhaPhytochemical Studies on Cissus

quadrangularis Linn.Pharmacognosy research.2009; 1(4) : 213-215.

214

34. Ampai Panthong, Wanicha Supraditaporn, Duangta Kanjanapothi, Tawat Taesotikul, Vichai

Reutrakul,Analgesic, anti-inflammatory and venotonic effects of Cissus quadrangularis

Linn.Journal of Ethnopharmacology. 2007; 110 (2) : 264–270.

35. Klaokwan Srisook, Mullika Palachot ,Nadtaya Mongkol , Ekaruth Srisook , Songklod

Sarapusit . Anti-inflammatory effect of ethyl acetate extract from Cissus quadrangularis

Linn may be involved with induction of heme oxygenase-1 and suppression of NF-κB

activation. Journal of Ethnopharmacology. 2011; 133(3): 1008–1014.

36. Emmanuel T. Nyahangare, Thokozani Hove, Brighton M. Mvumi, Humphrey

,Hamudikuwanda1, Steven R. Belmain, James Madzimure1 and Philip C. Stevenson. Acute

mammalian toxicity of four pesticidal plants. Journal of Medicinal Plants Research. 2012 ;

6(13): 2674-2680.

37. Enechi, O.C., Igbonekwu Celestina N and Ugwu Okechukwu P.C. Effects of ethanol extract of Cissus

quadrangularis on induced gastric ulcer in rats. Afrinal of biotechnology. 2013; 12 (43) : 6197-6202.

38. Suresh Kumar, Reecha Madaan, Gundeep Bansal, Anupam Jamwal, Anupam Sharma.Plants and

Plant Products with Potential Anticonvulsant Activity – A Review. Pharmacognosy Communications.

2012; 2 (1): 3-97.

39. Arumugam S, Palanivelu A, Retnasamy G and Ramaiyan D.Study on the anti-seizure

activities of inner bark of Guettarda speciosa (L.). Iranian journal of pharmacology &

therapeutics. 2009; 8: 73-76.

215

CHAPTER 3 EXTRACTION AND PHYTOCHEMICAL ANALYSIS:

1. Evans WC. Pharmacognosy, 16th edition. Saunders Elsevier, Edinburgh. 2009; 3-4.

2. Barrett M. The Hand Book of Clinically Tested Herbal Remedies, 1st edition, CBS

Publishers and Distributers, New Delhi. 2007; 3-6.

3. Sharma PC, Bhatia V et al., A Review on Bael Tree. Natural Product Radiance. 2007; 6(2): 171-

178.

4. Yadav NP, Chanotia CS. Phytochemical and Pharmacological Profile of Leaves of Aegle

marmelosLinn. The Pharma Review. 2009; 144-149.

5. Nugroho AE, Riyanto S et al., Effects of Aegline a Main Alkaloid of Aegale Marmelos Correa

Leaves, on The Histamine Release from Mast Cells. Pak. Journal of Pharmaceutical Science.

2011; 24(3): 359-367.

6. Nugroho AE, Riyanto S et al., Effect of Skimmianine, A Quinoline Alkaloid of Aegle marmelos

Correa Root, on the Histamine Release from Rat Mast Cell. Journal of Basic and Applied

Science. 2010; 6(2): 141-148.

7. Johnson M. Biochemical Variation Studies in Aegle marmelos (L) Corr-A Medicinally Important

Plant. Journal of Chemical and Pharmaceutical Research. 2010; 2(6): 454-462.

8. Indian Medicinal Plants, Orient Longman Ltd., Madras. 1992; 2: 112.

9. The Ayurvedic Pharmacopoeia of India, 1st edition Government of India, Ministry of Health and

Family Welfare, New Delhi. 2000; 1(I): 21, 22, 390, A-100.

10. The Wealth of India: A Dictionary of Indian Raw materials and Industrial Products, CSIR, New

Delhi. 2000b; III: 593-594.

11. Quality control Methods for Medicinal plant Materials, World Health Organization, Geneva, 1st.,

A.I.B.T.S. publishers and Distributors, New Delhi: 2002; 68-69.

216

12. Paulsen BS, Sekou B, Drissa D, Ann JK, Adsersen A. Antiplasmodial and GABAA-

benzodiazepine receptor binding activities of five plants used in traditional medicine in Mali,

West Africa. Journal of Ethnophramacology. 2007; 110: 451-457.

CHAPTER 4 OBJECTIVES OF THE PRESENT STUDY:

1. Sharma BK. Instrumental methods of chemical analysis. 26th edition, GOEL Publishing

House, Meerut. 2007; 401.

2. Kokate CK. Practical Pharmacognosy, IV edition, M.K.Jain, Vallabh Prakashan, Delhi. 1994;

286.

3. Laurence MH, Christopher JM. Experimental organic chemistry: Principles and Practice.

159–173.

4. Vogel AI. Vogel's Textbook of Practical Organic Chemistry. 5th Edition.

5. http://WWW.reachdevices.com/TLC.html.

6. Harborne JB. Phytochemical Methods - A guide to Modern Technique of plant analysis. 3rd

edition, Springer publication. 2007; 52-80.

7. Clarke’s Isolation and Identification of drugs. II edition, The plant pharmaceutical Press,

London. 1986; 90-95.

8. Beckett AH and Stan JB. (2005). Practical Pharmaceutical Chemistry, IV edition, CBS

Publishers, Delhi. 2005; 2: 86-91.

9. Kapil A, Koul IB, Banerjee SK and Gupta BD. Biochem. Pharmacol. 1993; 46: 182.

217

CHAPTER 5 ACUTE TOXICITY AND CHRONIC TOXICITY STUDIES:

1. Rhodes C, Thomas M, Athis J. Principles of testing for acute toxic effects. In:

General and Applied Toxicology. Stockton Press (New York), 1993; 49-87.

2. OECD, 2002. Acute oral toxic class method guideline 423 adopted 23.03.1996. In:

Eleventh Addendum to the, OECD, guidelines for the testing of chemicals Organisation

for Economical Co-operation and Development, Paris, June, 2000; 253-270.

3. Hodgson E and Smart RC. eds. Introduction to Biochemical Toxicology, 3rd ed. New York:

Wiley, 2001.

4. Hodgson E, Mailman RB, and Chambers JE. Dictionary of Toxicology, 2nd ed. London:

Macmillan, 1998; 508.

5. Klaassen CD. ed. Casarett and Doull’s Toxicology: The Basic Science of Poisons, 6 th ed.

New York: Mc Graw-Hill, 2001; 1123-1140.

6. Timbrell JA. Principles of Biochemical Toxicology, 3rd ed. London: Taylor and Francis,

2000. 299-305.

7. Wexler P. Information Resources in Toxicology, 3rd ed. San Diego: Academic Press, 2000;

1235-1238.

8. Mukinda JT, Syce JA.Acute and chronic toxicity of the aqueous extract of Artemisia afra

in rodents. Journal of Ethnopharmacology. 2007; 112: 138–144.

9. Uhe G. Medicinal plants of Samoa. A preliminary survey of the use of plants for medicinal

purposes in the Samoan Islands. Econ. Bot. 1974; 28: 1-30

10. Crossland J, In: Lewis Pharmacology, 5th edn, Churchill Livingston, Edinburgh, 1980; 656.

11. Dacie JV, Lewis SM, In:Practical Hematology, J and A Churchill Ltd. London, 1958; 38.

218

12. Wintrobe MM, Lee GR, Goggs DR, Forester J, In: Clinical Hematology, Lee and Febiger,

Philadelphia, 7th ed, 1994; 49.

13. Oser BL, Tata Mc- Graw Hill. In : Hawk’s Physiological Chemistry Book, Company Ltd.

New Delhi, 14th ed, 1965: 1035 - 1088.

14. Luna LG. Manual of Histological Staining Methods of Armed Forces Institute of Pathology.

McGraw Hill, WA. 1968.

15. Obici S, Otobone JF, daSilva Sela VR, Ishida K, da Silva JC, Nakamura CV, Cortez, DAG,

Audi EA.Preliminarytoxicitystudyofdichloromethane extract of Kielmeyera coriacea stems

inmice and rats. Journal of Ethnopharmacolog. 2008; 115:131–139.

16. Tomlinson TR, Akerele O. Medicinal Plants their Role in Health and Biodiversity.

University of Pennsylvania Press, Philadelphia, 1998.

17. Harper HA. Review of Physiological Chemistry, 14th ed. Lange Medical Publications,

California 1973.

18. Adeneye AA, Ajagbonna OP, Adeleke TI, Bello, S.O. Preliminary toxicity and

phytochemical studies of the stem bark aqueous extract of Musanga cecropioides in rats.

Journal of Ethnopharmacology. 2006; 105: 374–379.

19. Hilaly EJ, Israili ZH, Lyoussi B. Acute and chronic toxicological studies of Ajuga Iva in

experimental animals. Journal of Ethnopharmacology. 2004; 91: 43–50.

20. Rahman M., Siddiqui MK, Jamil K. Effects of Vepacide (Azadirachta indica) on aspartate

and alanine aminotransferase profiles in a sub chronic study with rats. Journal of Human and

Experimental Toxicology. 2001; 20: 243–249.

21. Wolf PL, Williams D, Tsudaka T, Acosta L. Methods and Techniques in Clinical Chemistry.

John Wiley & Sons, USA. 1972

219

CHAPTER 6 ANTI MICROBIAL AND CYTOTOXICITY STUDIES:

1. Burapadaja S, Bunchoo A. Antimicrobial activity of tannins from Terminalia citrina. Planta

Medica. 1995; 61: 365–366.

2. Adenisa SK, Idowu O, Ogundaini AO, Oladimeji H, Olugbade TA, Onawunmi GO, Pais M.

Antimicrobial constituents of the leaves of Acalypha wilkesiana and Acalypha hispida.

Phytother Res. 2000; 14: 371–374.

3. Graybill JR. Systemic fungal infections: diagnosis and treatment. Therapeutic agents.

Infectious Disease Clinics of North America. 1988: 805–825.

4. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg. 1996; 171: 374–

382.

5. Gonzalez CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors for fungemia

in children infected with human immunodeficiency virus: a case-control study. Clin Infect

Dis. 1996; 23: 515–521.

6. Sieradzki K, Wu SW, Tomasz A. Inactivation of the methicillin resistance gene mecA in

vancomycin-resistant Staphylococcus aureus. Micro Drug Resist. 1999; 5(4): 253–257.

7. Yusuf M, Chowdhury JU, Wahab MA. and Begum J. Medicinal plants of Bangladesh.

Premirer enterprise, Chittagong. 1994, 8-149.

8. Dranghon FA. Use of botanicals as biopreservatives in foods. Food Technol. 2004; 58: 20-

28.

9. Uniyal SK, Singh KN, Jamwal P and Lal B. Aloe ferox and Withan ia somnifera inhibit

Traditional use of medicinal plants among the tribal Candida albicans and Neisseria

gonorrhoea. Communities of Chhota Bhangal, Western Himalayan. African J. Biotechnol. 2006;

7: 12-15.J.

220

10. Bollinger WH. Natural plant chemicals: activity of Oxalis corniculata: A known medicinal

Sources of Industrial and Medicinal materials. Plant. My. Science. 1985; 1: 72-78.

11. Towers GHN. Screening of selected antifungal activity of some South African medicinal

plants of Nepal for antimicrobial activities. Plants. S. Afri. J. Bot. 1995; 68: 72-76.

12. Palombo EA and Semple SJ. Antibacterialactivity of traditional medicinal plants. Journal of

Ethnopharmacology. 2001; 77: 151-157.

13. Mukesh Kr. Singh, Pankaj Sahu, K. Nagori, D. Dewangan, T. Kumar. A. Alexander, H.

Badwaik and D.K Tripathi.Organoleptic properties in-vitro and in-vivo pharmacological

activities of Calendula officinalis Linn: An over review. Journal of Chemical and

Pharmaceutical Research. 2011; 3(4):655-663

14. Samuelsson G. Drugs of natural origin: a textbook of pharmacognosy.4th

ed., Stockholm,

Swedish Pharmaceu-tical Press, 1999.

15. Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development.

Journal of Natural Products. 1997; 60: 52-60.

16. Cragg GM, Newman DJ. Plants as source of anticancer agents. Journal of

Ethnopharmacology. 2005; 100: 72-79.

17. Kappor LD. CRC Handbook of ayurvedic medicinal plants. Boca Raton, Florida, CRC Press,

1990, 416-17.

18. Farnsworth NR, Akerele O, Bingel AS, Soejarto DD, Guo Z. Medicinal plants in therapy.

Bull World Health Organ. 1985; 63: 965-81.

19. Newman DJ, Cragg GM, Snader KM. The influence of natural products upon drug discovery.

Nat Prod Rep. 2000; 17(3): 215-234.

221

20. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants Life Sci. 2005; 78: 431-

441.

21. Richardson MA. Biopharmacologic and herbal therapies for cancer: research update from

NCCAMJ. Nutr. 2001; 131(11): 3037S-3040S

22. Itharat A, Houghton PJ, Eno-Amooquaye E, Burke PJ, Sampson JH, Raman A In vitro

cytotoxic activity of Thai medicinal plants used traditionally to treat cancer Journal of

Ethnopharmacology. 2004; 90: 33-38

23. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin.

2005, 55; 74-108.

24. Hartwell JL. Plants used against cancer: a survey. Lawrence MA. Quarterman Publications,

1982, 438-39.

25. Shoeb M. Cytotoxic compounds from the Genus Centaurea. PhD Thesis. Aberdeen, UK, the

Robert Gordon Univer-sity, 2005.

26. Hill RA. Naturally occurring isocoumarins. Chem Org. Naturst. Fortschr. 1986; 49: 1D78.

27. Whyte AC, Gloer JB, Scott JA and Malloch D. Cercophorins A-C: Novel antifungal and

cyto-toxic metabolites from the coprophilus fungus Cercophora areolata. J. Nat. Prod. 1996;

59: 765-769.

28. Shureiqi I, Reddy P, Banner DE. Chemoprevention: General perspective. Crit. Rev. Oncol.

/Hematol. 2000; 33: 157-167.

222

CHAPTER 7 INVITRO AND INVIVO ANTIOXIDANT ACTIVITY:

1. Hargguchi H. Anti-oxidative plant constituents. In Bioactive compounds from natural

sources, first published New York: Taylor and Francis Inc. 2001; 338-377.

2. Aruoma OJ. Assesment of potential prooxdant and antioxidant actions. Journal of the

American Oil Chemists society (IAOCS). 1996; 73(12): 1617-1625.

3. Polterait O. Antioxidants and free radical Scavengers of Natural origin. Current Org. Chem.

1997; 1: 415-440.

4. World Cancer Research Fund/American Institute for Cancer Research Food, Nutrition and

the Prevention of Cancer: A global Perspective American Institute for Cancer Research

Washington, DC. 1997.

5. U. S. Department of Agriculture, U. S. Department of Health, Human Services Nutrition and

Your Health: Dietary Guidelines for Americans U. S. Government Printing Office

Washington, DC. 1995.

6. American Heart Association Dietary guidelines for healthy American adults. Circulation.

1996; 94:1795-1800.

7. Repetto MG, Llesuy SF. Antioxidant properties of natural compounds used in popular

medicine for gastric ulcers. Braz. J.Med. Biol. Res. 2002; 35(35):523-534.

8. Collier A, Wilson R, Bradley H, Thomson JA, Small M. Freeradical activity in type 2

diabetes. Diabetes. 1990; 7: 27-30.

9. Kranner I, Beckett RP, Wornik S, Zorn M, Pfeifhofer HW. Revival of a resurrection plant

correlates with its antioxidant status. The Plant Journal. 2002; 31(1):13-24.

223

10. Koleva II, Van Beek TA, Linssen JPH, De Groot A, Evstatieva LN. Screening of plant

extracts for antioxidant activity, a comparitive study on three testing method. Phytochemical

analysis. 2002; 13: 8-17.

11. Cerutti P. Oxy-radicals and cancer. Lancet. 1994; 344: 862-863.

12. Adams JD, Odunze IN. Oxygen free radicals and Parkinson disease. Free Radical Biol. Med.

1991; 10:161-169.

13. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB,Kromhout, D. Dietary antioxidant

flavonoids and risk of coronary heart disease: the Zutphen elderly study. Lancet. 1993; 342:

1007-1011.

14. Stanner SA, Hughes J, Kelly CN, Buttress JA. Review of the epidemiological evidence for

the ‘antioxidant hypotheses. Pub. Health. Nutr. 2004; 7: 407-422.

15. Shureiqi I, Reddy P, Banner DE. Chemoprevention: General perspective. Crit. Rev. Oncol.

/Hematol. 2000; 33: 157-167.

16. Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. Cancer. J. Clin. 2004; 54: 150-

180.

17. Hu C. Kitts DD. Studies on the antioxidant activity of Echinacea root extract. J. Agric. Food

Chem. 2000; 48: 1466-1472.

18. Farag RS, Badei AZMA, Hawed FM, El-Baroty GSA. Antioxidantactivity of some spice

essential oils on linoleic acid oxidation in aqueous media. J. Am. Oil. Chem. Soc. 1989; 66:

793-799.

19. Bulger EM and Maier RV. Antioxidants in critical illness.Arch Surg. 2001; 136(10): 1201-7.

20. Faden AI et al.The role of excitatory amino acids and NMDA receptors intraumatic brain

injury.Science. 1989; 244(4906): 798-800.

224

21. Sen C, Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996;

10709- 720.

22. Pinkus R, Weiner L, Daniel V. Role of oxidants and antioxidants in the induction of AP-1,

NF-kB, and glutathione S-transferase gene expression. J Biol Chem. 1996; 271: 13422-

13429

23. Meyer M, Pahl HL, Baeuerle PA. Regulation of the transcription factors NF-kB and AP-1 by

redox changes. Chem Biol Interact. 1994; 9191- 100.

24. Packer L. Interactions among antioxidants in health and disease: vitamin E and its redox

cycle. Proc Soc Exp Biol Med. 1992; 200: 271- 276.

25. Gutteridge JMC, Halliwell B. Free radicals and antioxidants in the year 2000 – A historical

look to the future. Ann. N. Y.Acad. Sci. 2000:899; 136-147.

26. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the generative disease of

aging. Proc Natl Acad Sci USA. 1993; 90: 7915-7922.

27. Dean RT and Davies MJ. Reactive species and their accumulation on radical damaged

proteins. Trends Biochem Sci. 1993; 18: 437-441.

28. Niki E. Antioxidants. Free radicals and hiological defence. In: Niki, E., Shimasaki, H., Mino,

M. (Eds.), Japan Scientific Societies Press, Tokyo, 1995; 3.

29. Yagi K. Lipid peroxidation and human disease. Chem Phys Lipids. 1987; 45: 337-341.

30. Ames BN, Catheart R, Schwiers E, Hochstein P. Uric acid provides as antioxidant defense in

humans against oxidant and radical caused aging and cancer: a hypothesis. Proc Natl Acad

Sci USA. 1981; 78: 8658-62.

225

31. OECD, (2002) Acute oral toxicity. Acute oral toxic class method guideline 423 adopted

23.03.1996. In: Eleventh Addendum to the, OECD, guidelines for the testing of chemicals

organisation for economical co-operation and development, Paris June, 2000.

32. Gutteridge JMC and Wilkins C. Copper-dependent Hydroxyl Radical Damage to Ascorbic

Acid. Formation of a Thiobarbituric Acid Reactive Product. FEBS Letters. 1982; 137: 327-

40.

33. Marklund S and Marklund G. Involment of the superoxide anion radicle in the auto oxidation

of pyrogallol and a conveinent assay of superoxide dismutase. European J. of Biochem.

1974; 47: 469-474.

34. Beers RF and Sizer IW. A Spectrophotometric Method for Measuring the Breakdown of

Hydrogen Peroxide by Catalase. J Biol Chem. 1952; 195:130-140.

35. Dobler RE, Anderson BM. Simulatnious inactivation of the catalytic activities of yeast

glutatione reductase by N-alkyl melimides. Biochem. Biophys. Acta. 1981; 70: 65.

36. Lawrence RA, Burk RF. Glutathione peroxidase activity in selinium-deficient rat liver.

Biochemical and Biophysical Research Communication. 1976; 71: 952-958.

37. Quambo et al. Hepatoprotective activity of phenylethanoids from Cistanche. Planta Medica.

1998; 64: 120-125.

38. Frindivich I. The biology of oxygen radicals. Science. 1978; 201: 875-880.

39. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford University

Press, Newyork. 1999.

40. Marnett LJ. Oxy radicals, lipid peroxidation and DNA damage. Toxicology. 2002;181-182:

219-222.

226

41. McConnell HM and Hubbell WL. Molecular motion in spin-labelled phospholipids and

biomembranes. J Am Chem Soc. 1971; 93: 314-326.

42. Cooper RA, Durocher JR and Leslie MH. Decreased fluidity of red cell membrane lipids in a

beta lipoproteinemia. J Clin Invest. 1977; 60: 115-121.

43. Kawamori T, Tanaka T, Hirose Y, Ohniiishi M, Mori H. Inhibitory effect of d-limonene on

the development of aberrant crypt foci induced by azoxymethene in F344 rats.

Carcinogenesis. 1996; 17(2): 369-72.

44. So FV, Guthrie N, Chambers AF, Moussa M. Inhibiton of human breast cancer proliferation

and delay of memory tumorigenesis by flavonoids and citrus juices. Nutr Cancer. 1996;

26(2): 167-81.

45. Reddy BS, Wang CX, Samaha H. C hemoprevention of colon carcinogenesis by dietary

perillyl alcohol. Cancer Res. 1997; 57: 420-25.

46. Kinsella JE, Franeel E, German B, Kanner J. Possible mechanisms for the protective role of

antioxidants in wine and plant foods. Food Technology. 1993; 47(4): 85-90.

227

CHAPTER 8 ANTI INFLAMMATORY ACTIVITY:

1. Harsh Mohan. Inflammation and Healing, Text book of Pathology, Ed Jaypee Publication

(New Delhi), 2002: 114-121.

2. Brunton LL, Lazo JS, Parker KL. Goodman & Gilman's The Pharmacological Basis of

Therapeutics, 11th edition. Mc Graw-Hill (New York), 2006

3. Toby Lawrence, Derek A.Willoughby and Derek W.Gilroy. Anti-inflammatory lipid

mediators and insights into the resolution of inflammation. Nature reviews | immunology.

2002; 2: 787-795

4. Serhan CN, Chiang N. Novel endogenous small molecules as the check point controllers in

inflammation and resolution: entree for resoleomics. Rheum. Dis. Clin. North Am.2004;

30:69-95.

5. Winter CA, Risley EA, Nuss GW. Carrageenin-induced oedema in hind paws of the rat as an

assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 1962; 111: 544-547.

6. Brooks PM, Day RO. Nonsteroidal anti-inflammatory drugs: difference and similarities.

N.Engl. J. Med. 1991; 324:1716.

228

CHAPTER 9 ANTI EPILEPTIC ACTIVITY:

1. Reddy DS. Tigabine – a potent antiepileptic drug with selective GABA uptake inhibitory

effect. Ind J Pharmacol. 1998; 30: 141-151.

2. Leary JO. Science and Epilepsy. 1st edn., Newyork, Raven press 1970: 21-26.

3. Glanze WD, Kenneth NA, Lois EA. Mosby’s medical, nursing and Allied health dictionary,

New Delhi, Jaypee brothers. 1995.

4. Mathews WB. Practical Neurology Oxford, Biackwell Publications. 1963; 1: 40-62.

5. Namara JO. Drugs effective in the Therapy of Epilpsies. In: Joel G Hardman, Lee E Limbird,

editors. Goodman and Gillman’s The Pharmacological Basis of Therapeutics. 10 thEdn.

NewYork: McGraw Hill 2001: 527.

6. Sangeeta K, Garg KC. Seizures after administration of intravenous ligocaine for ventricular

arrythmia in a patient of acute myocardial infraction. Ind J Pharmacol. 1990; 22: 180-181.

7. Gupta N, Puri JN, Jain, Sharma MK. Potentiation of leptazole induced convulsions by

Metronidazole. Ind J Pharmacol. 1989; 21: 187-188.

8. Rane RC, Gandhi TP, Patel RB, Shad GF, Raval JD. Epileptogenioc properties of various

pencillins in mice. Ind J Pharmacol. 1985; 18: 178-179.

9. Otoom S, Hakam Al Hadida. Seizure induced by antiepileptic drugs. Annual of Saudi

Medicine. 2000; 20(3-4): 316-318

10. Hosford DA and Wang Y. Utility of the lethargic mouse model of absence seizures in

predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate

against human absence seizures. Eur J Epilepsy. 1997; 38(4): 408-14.

229

11. Gupta M, Sasmal D, Sumitra DG and Begchi GK. Changes of epinephrine,noradrenaline,

dopamine in mice brain and liver and 5 HT in mice brain following treatment with

ochratoxin and citrinin. Ind J Pharmacol. 1984; 16: 102-106.

12. Kulkarni SK. Hand book of experimental pharmacology. 3rdedn. New

Delhi:Vallabhprakashan, 2004: 20-43.

13. Shiv Kumar, Kulkarni SK. Influence of antidepressant drug on learning and memory in

mice. Ind J Exp Biol. 1995: 34: 431-435.

14. Sharma A, Parikh V, Sing M. Pharmacological basis of drug therapy of alzheimer s disease.

Ind J Exp Boil. 1997; 35: 1146-1155.

15. Kulkarni SK and George B. Significance of long term potentiation in cognitive functions and

epilepsy. Ind J Pharmacol. 1999; 31: 14-22.

16. Satyan KS, Rai A, Jaiswal AK, Acharya SB, Bhattacharya SK. Istatin, a mutative

anxiogenicendocoid, induces memory dysfunction in rats. Ind J Exp Biol. 1995; 33: 576-579.

17. Bhaduri J, Hota D, AcharyaSB. Role of prostaglandin synthesis inhibitor on chemically

induced seizures. Ind J Exp Biol. 1995; 33: 677-681.

18. Srinavas V, HaranathBabu M, Narendra Reddy T, Diwan AV. Modulation of

neurotransmitters in mice brains by an anticonvulsant principal. Ind J pharmacol. 1997; 29:

296-300.

19. Narasapur N, Dashputra P. Potentiation of catalepsy produced with subcataleptic doses of

prazosin and haloperidol in albino rats. Ind J Pharmacol. 1995; 27: 139-140.

20. Tripathi KD. Drugs used in mental illness in; essentials of medical pharmacology. 4thedn.,

New Delhi: Jaypee Brothers. 1999: 403-408.

230

21. Bhattacharya D, Lahiri HL, Roy G, Bandhopadhya SK. Metoclopramide catalepsy in rats,

pharmacological study of its mechanism. Ind J pharmacol. 1983; 15(3):203-208.

22. Paterson D.S. Multiple serotonergic brainstem abnormalities in sudden infant death

syndrome. Journal of the American Medical Association. 2006; 296: 2124–2132.

23. Shankar PR, Karan S, Handu SS, Bhargava VK. Effect of ondansetron on haloperiodal

induced catalepsy. Ind J Pharmacol. 1999; 31: 376-377.

24. Bonta IL. Pharmacology of GABA like compounds in relation to the brain dopaminergic

system. Ind J pharmacol. 1973; 5(3): 349-373.

25. Turner RA. Anticonvulsants, In;screening procedures in pharmacology, Newyork, Acadamic

press, 1972; 163-173.

26. Swinyard EA. Laboratory evaluation of antiepileptic drugs. Review of laboratory methods.

Epilepsia. 1969; 10: 107-19.

27. Kulkarni SK, AshishDhir, Pattipati S. Naidu. Effect of cyclooxygenase inhibitors on

pentylenetetrazol (PTZ)-induced convulsions: possible mechanism of action. Neuro-

Psychopharmacology & Biological Psychiatry. 2006; 30: 1478-1485.

28. Margret Schlumf, Walter Lichtensteiger, Heinrich Langemann, Peter G.Waser, Franz Hefti.

A fluorometric micro method for the simultaneous determination of serotonin, dopamine and

nor-adrenaline in milligram amount of brain tissue. Biochemical Pharmacology; pergamon

press zurich, Switzerland. 1974; 2337-2446.

29. Ralph Clinkers, SARAH Gheuens, Ilse Smolders. In vivo modulatory action of extracellular

glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin. Epilepsia.

2005; 46(6): 828-836.

231

30. Heinemann UE, Draghun E, Fickern J, Stabel and Zhang CL. Strategis for the development

of drugs for pharmacological resistant epilepsies. Epilepsia. 1994; 35: S10- S21.

31. Lowe IP, Robins E, Eyerman GS. The fluorimetric measurement of glutamic decarboxylase

measurement and its distribution in brain. J Neuro chem. 1958; 3: 8– 18.

32. Raza MF, Shaheen MI, Choudhary A, Suria AU, Rahman S, Sombati and Delorenzo RJ.

Anticonvulsant activities of the FS-1 Sub-fraction isolated from roots of Delphinium

denudatum. Phytother. Res. 2001; 15: 426-430.

33. LoscherW, Schmidt D. Which animal models should be used in the search for new

antiepileptic drugs? A proposal based on experimental and clinical consideration. Epilepsy

Res. 1988; 2: 145-181.

34. Oliveira FA, Almeida RN, Sousa MFV, Barbosa-Filho JM, Diniz SA, Medeiros IA.

Anticonvulsant properties of N-salicyloyltryptamine in mice. PharmacolBiochemBehav.

2001; 68: 199-202.

35. Quintans-Junior LJ, Almeida RN, Falcao ACGM, Agra MF, Sousa MFV, Barbosa-Filho JM.

Avaliação da Atividadeanticonvulsivante de plantas do NordesteBrasileiro. Acta Farm

Bonaerense. 2002; 21: 179-184.

36. Stables JP, Kupferberg HJ. The NIH Anticonvulsant Drug Development (ADD) Program:

Preclinical Anticonvulsant Screening project. In: Antiepileptic Drugs, 4th edn. Ed. Levy RH,

Mattson RH, Meldrum BS, Raven Press, New York. 1995: 4–17.

37. Kupferberg HJ. Antiepileptic drug development program: a cooperative effort of government

and industry. Epilepsia. 1989; 30 (Suppl 1): S51–S56.

38. Macdonald RL and Kelly KM. Antiepileptic drug mechanisms of action. Epilapsia. 1995; 36:

S2-S12.

232

39. White HS. Clinical significance of animal seizure models and mechanism of action studies of

potential antiepileptic drugs. Epilepsia. 1997; 38 (Suppl. 1): 9.

40. Ramanjaneyulu R, Ticku MK. İnteractions of pentamethylenetetrazole and tetrazole

analogues with the picrotoxinin site of the benzodiazepine- GABA receptor-ionophore

complex. Eur. J. Pharmacol. 1984; 98: 337–345.

41. De Deyn PP, D’Hooge R, Marescau B and Pei YQ. Chemical model of epilepsy with some

reference to their applicability in the development of anticonvulsant. Epilepsy Res. 1992; 12:

87-110.

42. Macdonald RL, McLean MJ. Cellular bases of barbiturate and phenytoin anticonvulsant drug

action. Epilepsia. 1982; 23: 7-18.

43. Santhakumar V, Wallner M, Otis TS. Ethanol acts directly on extra synaptic subtypes of GABAA

receptors to increase tonic inhibition. Alcohol.2007; 3:211-21.

44. Coulter DA, Hugenard JR and Prince DA. Characterization of the ethosuximide reduction of

low-threshold calcium current in thalamic neurons. Ann. Neurol. 1989; 25: 582-593.

45. Bagdy G, Kecskemeti V, Riba P, Jakus R. Serotonin and epilepsy. J. Neurochem. 2007; 100: 857—

873.

46. Starr MS. The role of dopamine in epilepsy. Synapse. 1996; 22: 159—194.

47. Applegate CD, Burchfiel JL, Konkol RJ. Kindling antagonism: effects of norepinephrine depletion

on kindled seizure suppressionafter concurrent, alternate stimulation in rats. Exp. Neurol. 1986; 94:

379–390.

48. Corcoran ME. Characteristics of accelerated kindling after depletion of noradrenaline in adult rats.

Neuropharmacology. 1988; 27: 1081–1084.

49. McIntyre DC, Edson N. Kindling-based status epilepticus: effects of norepinephrine depletion with 6-

hydroxydopamine. Exp. Neurol. 1989;104: 10–14.

50. Pelletier MR Corcoran ME. Infusions of alpha-2 noradrenergic agonists and antagonists into the

amygdala: effects on kindling. Brain Res. 1993; 632: 29–35.

233

51. Yan QS Jobe PC. Dailey JW. Further evidence of anticonvulsant role for 5- hydroxytryptamine in

genetically epilepsy-prone rats. Br.J. Pharm. 1995; 115: 1314–1318.

52. Zis AP, Nomkos GG, Brown EE, Damsa G, Fiberger HC. Neurochemical effects of electrically and

chemically induced seizures: and in vivo microdialysis study in hippocampus.

Neuropsychopharmacology. 1992; 7: 189–195.

53. Sheridan, P. F. Uptake, metabolism, and distribution of DDT in organs of the blue crab, Callinectes

sapidus. Chesapeake Sci.1975; 16: 20-26.